Karyotyping for Doctors – Comprehensive Chromosomal Analysis

Karyotyping for Genetic Diagnosis

Karyotyping is a fundamental cytogenetic technique used to visualize and analyze an individual's chromosomes. It allows for the detection of numerical chromosomal abnormalities (aneuploidies) and large-scale structural rearrangements (e.g., translocations, deletions, duplications, inversions).

While newer technologies like chromosomal microarray (CMA) offer higher resolution for detecting copy number variations (CNVs), karyotyping remains a crucial diagnostic tool in various clinical settings, particularly for identifying balanced rearrangements and confirming suspected aneuploidies.

Key Applications

Indications for Karyotyping

Karyotyping is indicated in a range of prenatal, postnatal, and specialized scenarios:

Prenatal Diagnosis (from Amniotic Fluid - AF, or Chorionic Villus Sample - CVS):

Positive prenatal screening results (e.g., NIPT, first/second-trimester serum screening) suggesting aneuploidy.
Fetal structural anomalies detected on ultrasound.
Fetal structural anomalies detected on ultrasound.
Previous child with a chromosomal abnormality.
Advanced maternal age (though NIPT/CMA are often primary).
Family history of a condition diagnosable by karyotyping.

Postnatal Diagnosis (from Peripheral Blood):

Suspected aneuploidy syndromes (e.g., Down syndrome, Turner syndrome, Klinefelter syndrome).
Individuals with developmental delay (DD), intellectual disability (ID), or autism spectrum disorder (ASD), often as a complement to CMA.
Multiple congenital anomalies (MCA).
Disorders of sex development (DSD).
Primary amenorrhea or infertility (male and female).
Short stature of unknown etiology.

Other Applications:

Recurrent Pregnancy Loss (RPL): Parental karyotyping to detect balanced translocations or inversions.

Conditions Detected by Karyotyping:

Numerical Abnormalities (Aneuploidies):

Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Sex chromosome aneuploidies (e.g., Turner syndrome - 45,X; Klinefelter syndrome - 47,XXY; 47,XXX; 47,XYY)

Structural Abnormalities (if large enough, typically >5-10 Mb):

Deletions and Duplications
Translocations (balanced and unbalanced)
Inversions (paracentric and pericentric)
Ring chromosomes
Marker chromosomes

Mosaicism: Presence of two or more cell lines with different chromosomal constitutions (detection depends on the percentage of mosaicism and number of cells analyzed).

Platform & Methodology

Methodology: G-Banded Karyotyping

Sample Collection: Blood (in Sodium Heparin), AF, CVS.
Cell Culture: Cells (lymphocytes, amniocytes, chorionic villi cells, fibroblasts) are cultured in appropriate media to stimulate cell division.
Mitotic Arrest: A mitotic inhibitor (e.g., colcemid) is added to arrest cells in metaphase.
Hypotonic Treatment: Cells are treated with a hypotonic solution to swell them and disperse chromosomes.
Fixation: Cells are fixed, typically with a methanol:acetic acid fixative.
Slide Preparation: Fixed cells are dropped onto microscope slides and air-dried.
Banding: Slides are treated with trypsin and stained (e.g., Giemsa stain) to produce characteristic G-bands on chromosomes.
Microscopic Analysis: Chromosomes are visualized, counted, and analyzed for structural integrity by a trained cytogeneticist. Images are captured, and a karyogram is constructed.

Precision & Progress

Understanding Karyotype Results

Shipping Conditions : Room temperature or cold pack (depending on sample type).

Normal Female:

46,XX

Normal Male:

46,XX

Numerical Abnormality:

e.g., 47,XX,+21 (Female with Down syndrome)

Structural Abnormality:

e.g., 46,XY,t(9;22)(q34;q11.2) (Male with a balanced translocation between chromosomes 9 and 22)

Mosaicism:

e.g., mos 45,X[10]/46,XX[10] (Mosaic Turner syndrome with 10 cells showing 45,X and 10 cells showing 46,XX))

Clinical Guidelines

Clinical Guidelines Supporting Karyotyping Use

ACMG/ACOG: Recommend karyotyping for specific prenatal indications (e.g., confirming NIPT, parental translocation) and in certain postnatal evaluations (e.g., suspected aneuploidy, RPL workup).
Often used in conjunction with or as a follow-up to other genetic tests (NIPT, CMA).
Remains the gold standard for detecting balanced structural rearrangements.

Limitations of Karyotyping:

Numerical Abnormalities (Aneuploidies):

Lower resolution compared to CMA; cannot detect submicroscopic CNVs (< 5-10 Mb).
Cannot detect uniparental disomy (UPD) or regions of homozygosity.
Requires viable, dividing cells for analysis. Culture failure can occur.
Detection of mosaicism is limited by the number of cells analyzed and the tissue source.
Cryptic or complex rearrangements may be missed or misinterpreted.

Advantages of Choosing Suraksha Genomics for Karyotyping

Experienced Cytogeneticists: Highly skilled team performing analysis according to international standards.
High-Quality Chromosome Preparations: Optimized cell culture and banding techniques for clear results.
Comprehensive Reporting: ISCN nomenclature with clear clinical interpretations.
Integrated Genetic Services: Seamless access to complementary tests (CMA, FISH, NIPT) and genetic counseling.
Reliable Turnaround Times: Consistent delivery of results within the specified timeframe.

Consult our experts